Results 141 to 150 of about 2,535,651 (215)

Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment. [PDF]

Diabetes Obes Metab
Romanos M, Garcia Cordova JM, Villamarin J, Pazmino Zurita JD, Acosta A.   +4 more
europepmc   +1 more source

Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults. [PDF]

BMJ Med
Reinson T, Bilson J, Childs C, Buchanan RM, Targher G, Byrne CD.   +5 more
europepmc   +1 more source

Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review. [PDF]

Liver Int
van Eekhout KMA, Broekman LD, de Jong VD, Michel M, Grobbee R, Maya-Miles D, Romero-Gómez M, Muris J, Mendive JM, Vali Y, Franco OH, Schattenberg JM, Fournier-Poizat C, Castro Cabezas M, Tushuizen ME, Holleboom AG, GRIPonMASH consortium.   +16 more
europepmc   +1 more source

Association Between Periodontitis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study. [PDF]

Clin Exp Dent Res
Saito M, Shimazaki Y, Yoshii S, Kojima T.   +3 more
europepmc   +1 more source

EASL position paper on palliative care in advanced chronic liver disease. [PDF]

JHEP Rep
Verma S, Pinter M, Macken L, Künzler-Heule P, Gluud LL, Takkenberg B, Nunes R, Gheorghe L, Prentice W, Hudson B.   +9 more
europepmc   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations. [PDF]

Curr Obes Rep
Georgakopoulou VE, Steiropoulos P, Androutsakos T, Karabella I, Reppas K, Cholongitas E, Dalamaga M.   +6 more
europepmc   +1 more source

Successful GH Treatment of Hepatopulmonary Syndrome in Panhypopituitarism-related Advanced Liver Disease. [PDF]

JCEM Case Rep
Chen S, Diaz-Lankenau R, Kwong A, Chang J, McAvoy J, Lai YK.   +5 more
europepmc   +1 more source